| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel extracellular matrix-based leukemia model supports leukemia cells with stem cell-like characteristics
|
Li, Dandan
|
|
2018
|
72 |
C |
p. 105-112
|
artikel
|
| 2 |
A phase 1 study of chemosensitization with plerixafor plus G-CSF in adults with relapsed acute myeloid leukemia
|
Heiblig, Maël
|
|
2018
|
72 |
C |
p. 7-11
|
artikel
|
| 3 |
A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype
|
Wang, Ya-Zhe
|
|
2018
|
72 |
C |
p. 12-19
|
artikel
|
| 4 |
Association of recipient and donor hypercholesterolemia prior allogeneic stem cell transplantation and graft-versus-host disease
|
Rivera-Franco, Monica M.
|
|
2018
|
72 |
C |
p. 74-78
|
artikel
|
| 5 |
CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia
|
Garcia-Manero, Guillermo
|
|
2018
|
72 |
C |
p. 79-85
|
artikel
|
| 6 |
Clinical significance of novel SH2B3 mutations in adult Chinese acute lymphoblastic leukemia patients
|
Gu, Yan
|
|
2018
|
72 |
C |
p. 67-70
|
artikel
|
| 7 |
Combination of cabazitaxel and plicamycin induces cell death in drug resistant B-cell acute lymphoblastic leukemia
|
Nair, Rajesh R.
|
|
2018
|
72 |
C |
p. 59-66
|
artikel
|
| 8 |
Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation
|
Sommer, Sebastian
|
|
2018
|
72 |
C |
p. 20-26
|
artikel
|
| 9 |
Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia
|
Manukyan, Gayane
|
|
2018
|
72 |
C |
p. 113-119
|
artikel
|
| 10 |
Editorial Board
|
|
|
2018
|
72 |
C |
p. ii
|
artikel
|
| 11 |
Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)
|
Zeidner, Joshua F.
|
|
2018
|
72 |
C |
p. 92-95
|
artikel
|
| 12 |
Imatinib resistance due to a novel and rare class of mutation at position S348 (1043nt C→A) of Bcr/Abl gene in a chronic myeloid leukemia patient
|
Dhangar, Somprakash
|
|
2018
|
72 |
C |
p. 96-98
|
artikel
|
| 13 |
IRF4 in multiple myeloma—Biology, disease and therapeutic target
|
Agnarelli, Alessandro
|
|
2018
|
72 |
C |
p. 52-58
|
artikel
|
| 14 |
Nivolumab to control molecular response in chronic myeloid leukemia
|
Rousselot, Philippe
|
|
2018
|
72 |
C |
p. 5-6
|
artikel
|
| 15 |
Non-internal tandem duplication (ITD), non-tyrosine kinase domain (TKD) FLT3 mutations in myeloid malignancies: A brief report of 10 patients
|
Higgins, Alexandra
|
|
2018
|
72 |
C |
p. 1-4
|
artikel
|
| 16 |
Notch1 activation enhances proliferation via activation of cdc2 and delays differentiation of myeloid progenitors
|
Nakamura, Makoto
|
|
2018
|
72 |
C |
p. 34-44
|
artikel
|
| 17 |
Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia
|
Chen, Xue
|
|
2018
|
72 |
C |
p. 99-104
|
artikel
|
| 18 |
Secondary acute lymphoblastic leukemia, a retrospective analysis from Washington University and meta-analysis of published data
|
Ferraro, Francesca
|
|
2018
|
72 |
C |
p. 86-91
|
artikel
|
| 19 |
Targeting acute myeloid leukemia CD34+ stem/progenitor cells with small molecule inhibitor MK-8776
|
Lei, Hu
|
|
2018
|
72 |
C |
p. 71-73
|
artikel
|
| 20 |
The clinical significance of CDX2 in leukemia: A new perspective for leukemia research
|
Darvishi, Mina
|
|
2018
|
72 |
C |
p. 45-51
|
artikel
|
| 21 |
The IPSS-R has prognostic impact in untreated patients with MDS del(5q)
|
Kaivers, J.
|
|
2018
|
72 |
C |
p. 27-33
|
artikel
|
Tijdschrift beschrijving